Febrile Seizure Susceptibility and Your Genetics
By the ExomeDNA Research Team | Last reviewed 2026-05-29
This page contains general information only. For personal health decisions, consult a qualified clinician.
Febrile seizure susceptibility refers to a genetically influenced threshold at which a fever triggers a brief seizure, most commonly in children between six months and five years of age. Roughly 2–5% of children in this age window experience at least one febrile seizure, and genetic variants in ion channel genes — particularly SCN1A, SCN2A, and ANO3 — appear to shift where that threshold sits. Below: what the science currently shows, what these genes do, and what the evidence base looks like.
What is febrile seizure susceptibility?
A febrile seizure is a convulsion triggered by fever rather than by a primary brain condition. Most are simple: they last under five minutes, involve the whole body, and resolve on their own. The nervous system of young children is more sensitive to rapid temperature changes than that of older children and adults, which is why febrile seizures cluster tightly in the toddler years and typically resolve without treatment as the brain matures.
Susceptibility to febrile seizures is not all-or-nothing. Rather, it sits on a biological continuum shaped by multiple factors — developmental stage, the height and rate of rise of the fever, and a genetic background that sets the baseline excitability of inhibitory and excitatory neurons. The genetic variants identified in GWAS research do not cause febrile seizures directly; they adjust where on that continuum an individual's threshold falls. Two children running the same 39°C fever may respond very differently, and genetics is part of why.
The GWAS underlying this trait specifically studied febrile seizures that occur outside the context of MMR vaccination. This distinction matters: a well-known, transient post-MMR fever spike can provoke brief seizures in a small proportion of recipients, and that post-vaccine phenomenon has its own partially separate biology. The genetic signals here reflect constitutional susceptibility — the underlying neurological and ion-channel architecture that determines seizure threshold independent of any particular vaccination event.
The genetics behind febrile seizure susceptibility
Three genes are central to the biology of temperature-sensitive seizure threshold: SCN1A, SCN2A, and ANO3. Each operates at a different point in the circuit connecting fever to neuronal excitability.
SCN1A encodes the Nav1.1 sodium channel, the principal sodium current generator in fast-spiking GABAergic interneurons — the inhibitory neurons that keep excitatory activity in check throughout the cortex and hippocampus. Nav1.1 has a distinctive and well-characterized property: it is thermosensitive. As body temperature rises during fever, Nav1.1's sodium current is disproportionately reduced compared to sodium channels in excitatory neurons. The result is selective impairment of inhibitory interneuron firing at elevated temperatures, while excitatory neurons remain relatively unaffected. The excitatory-inhibitory balance tips toward excitation, and the seizure threshold drops.
This mechanism is most dramatically illustrated by Dravet syndrome, a severe epilepsy caused by loss-of-function mutations in SCN1A, where even modest fevers can trigger prolonged, life-threatening seizures. Common variants near SCN1A identified in GWAS studies — including the study by Feenstra and colleagues (2014) — do not produce Dravet syndrome. They shift the temperature-sensitivity of Nav1.1 by smaller, graded degrees, adjusting seizure threshold in the general population rather than abolishing inhibitory interneuron function outright.
SCN2A encodes Nav1.2, a sodium channel with a different expression profile: it is most abundant in excitatory pyramidal neurons, particularly during early postnatal brain development. Where SCN1A acts primarily through the inhibitory side of the circuit, SCN2A acts through the excitatory side. Elevated body temperature alters Nav1.2 gating kinetics in developing cortical neurons, potentially lowering the firing threshold and increasing spontaneous activity in immature excitatory circuits. The combination of reduced inhibitory drive (SCN1A pathway) and heightened excitatory excitability (SCN2A pathway) during fever creates compounding pressure on the seizure threshold.
ANO3 — also called TMEM16C or anoctamin 3 — encodes a calcium-activated chloride channel in the TMEM16 family. ANO3 is expressed in the thalamus, a relay station that routes sensory and physiological signals including temperature information to the cortex. ANO3 channels have heat-activated properties: at elevated temperatures, ANO3 current increases, altering membrane potential in temperature-sensitive thalamic circuits. Variants in ANO3 may affect how efficiently the thalamus amplifies or dampens the fever signal before it reaches cortical structures. This is a different entry point into the fever-seizure pathway than the direct sodium channel mechanisms of SCN1A and SCN2A — it sits at the temperature-sensing relay layer rather than at the inhibitory or excitatory neuron level.
Together, these three genes span inhibitory neurons (SCN1A), excitatory neurons (SCN2A), and thalamic temperature-sensitive circuits (ANO3), suggesting that constitutional febrile seizure susceptibility is a polygenic property built from multiple layers of ion channel biology responding to the common challenge of elevated body temperature.
What the research says
Research base: Moderate. The genetic signals underlying this trait come from a 2014 GWAS by Feenstra and colleagues (Feenstra 2014) that identified common variants associated with febrile seizures. The study specifically stratified for MMR vaccine-unrelated febrile seizures, isolating constitutional susceptibility from the post-vaccination context. The loci identified near SCN1A, SCN2A, and ANO3 reached genome-wide significance in this cohort, providing a statistically robust signal despite the single-study evidence base. Replication across independent cohorts and additional population groups is more limited than for traits with a decade-plus of multi-cohort GWAS data, which is why this trait is classified at the moderate rather than robust confidence tier.
For the scoring framework underlying every percentile in your ExomeDNA report, see our methodology page for the full statistical approach.
The mechanistic case for SCN1A's role in febrile seizure biology is among the strongest in the epilepsy genetics field, reinforced by decades of functional and clinical research on Dravet syndrome and related channelopathies. The GWAS signals near SCN1A align precisely with what the channel biology predicts, lending the moderate-evidence tier additional biological plausibility that goes beyond the p-value alone.
Febrile seizures themselves are well-characterized epidemiologically: they are the most common seizure type in childhood, affecting approximately 2–5% of children in the six-month to five-year age window. The large majority — roughly 70–75% — are simple febrile seizures (brief, generalized, resolving without intervention). The remaining 25–30% are complex febrile seizures, defined by duration exceeding 15 minutes, focal features, or recurrence within the same illness episode. The distinction matters: simple febrile seizures carry no meaningful increase in risk for later epilepsy, while complex febrile seizures are associated with a modestly elevated risk that warrants clinical evaluation.
Genetic susceptibility as characterized in the Feenstra 2014 study reflects constitutional threshold variation in the general population — it is not a measure of individual seizure severity or a predictor of Dravet syndrome. Individuals carrying variants near SCN1A, SCN2A, or ANO3 who have experienced febrile seizures have almost always experienced the simple, self-limiting variety. The genetic signal shifts probability within the typical range of febrile seizure biology, not outside it.
How febrile seizure susceptibility affects you
For most families, febrile seizure susceptibility is relevant during the years from roughly six months to five years — the window when the developing brain is most sensitive to rapid temperature rises. After this window, febrile seizures typically resolve as part of normal neurological maturation, regardless of genetic background.
A child who has experienced a febrile seizure has approximately 30% chance of experiencing a second one — higher when a first-degree relative has a history of febrile seizures. Genetic susceptibility variants likely contribute to this familial clustering.
Simple febrile seizures, even when frightening to witness, do not cause brain damage — they reflect a brief disruption in the excitatory-inhibitory balance that resolves as the brain's temperature-sensing circuits restabilize.
ICD-10 distinguishes simple febrile convulsions (R56.00) from complex febrile convulsions (R56.01). A pediatrician or neurologist will classify a febrile seizure based on duration, focal vs. generalized features, and whether it recurs within the same illness — not on genetic background alone. Genetic results are most useful as a conversation prompt with a clinician, not as a standalone risk determination.
What genetic susceptibility does not predict: the specific trigger fever height, the developmental course after febrile seizures cease, or the likelihood of epilepsy in the absence of complex febrile seizure features. The vast majority of children with genetically elevated susceptibility who experience febrile seizures never develop epilepsy.
Working with your febrile seizure susceptibility result
If this result is relevant to your family — either because of personal history of febrile seizures or as prospective context before the childhood fever years — the following steps represent the current clinical consensus on febrile seizure management and preparedness.
Discuss the result with your child's pediatrician. A genetic result indicating higher susceptibility is useful clinical context, particularly before vaccination appointments where a brief fever spike is possible. Pediatricians can tailor post-vaccination monitoring and fever management plans based on individual and family history.
Build a fever management plan before it's needed. Prompt use of acetaminophen or ibuprofen at the onset of fever may reduce the peak temperature rise, which is the primary physiological trigger. Consult a pediatrician for appropriate dosing by age and weight, and for guidance on when to start treatment rather than waiting.
Know febrile seizure first aid. If a febrile seizure occurs: place the child on their side on a flat surface, time the duration from onset, do not restrain movement, do not place anything in the mouth, and do not attempt to stop the seizure. Call emergency services if the seizure exceeds five minutes, if the child does not recover consciousness promptly after the seizure ends, or if a second seizure occurs during the same illness.
Recognize complex febrile seizure features requiring immediate evaluation. Duration beyond 15 minutes, focal features (one limb or one side of the body involved), and recurrence within the same illness episode all define complex febrile seizures. These warrant same-day or emergency evaluation, not watchful waiting.
Maintain adequate hydration during febrile illness. Fluid intake supports temperature regulation. Dehydration during fever can worsen temperature dysregulation and increase physiological stress on thermoregulatory circuits.
Understand the EEG question. A routine EEG is not recommended after a simple febrile seizure and will not meaningfully change management. Neurologist referral and EEG are appropriate after complex febrile seizures or when the clinical picture is unclear — the standard of care after a typical simple febrile seizure is reassurance and fever management planning, not investigation.
Related traits and genes
Febrile seizure susceptibility shares biological architecture with several other traits in the ExomeDNA nervous system and neurological category. Ion channel variants that shape neuronal excitability and temperature sensitivity overlap with a range of related phenotypes:
- Epilepsy Risk — complex febrile seizures and epilepsy share overlapping genetic architecture, including variants in SCN1A; understanding one provides context for the other.
- Migraine Susceptibility — migraine and febrile seizures share a neuronal excitability dimension; both involve threshold phenomena in cortical circuits.
- Pain Sensitivity — ion channel variants that affect sensory neuron excitability in temperature-sensitive circuits overlap with the ANO3 pathway implicated in febrile seizure susceptibility.
- Anxiety and Stress Response — GABAergic interneuron function, central to SCN1A biology, also shapes tonic inhibitory tone in circuits involved in stress and anxiety responses.
- Sleep Architecture — thalamic relay circuits central to the ANO3 angle in febrile seizure susceptibility also regulate sleep-wake transitions and slow-wave sleep generation.
Frequently asked questions
Are febrile seizures dangerous?
Simple febrile seizures — the vast majority — are not dangerous. They do not cause brain damage, they do not indicate neurological disease, and they almost always resolve within two to three minutes without intervention. The experience is frightening for caregivers, but the seizure itself reflects a temporary, self-limiting disruption of the excitatory-inhibitory balance during fever. Complex febrile seizures, defined by duration over 15 minutes, focal features, or recurrence in the same illness, are a different category and warrant prompt clinical evaluation. Most children who experience febrile seizures, including those with genetic susceptibility variants, will never experience a complex febrile seizure.
Does genetic susceptibility mean my child will definitely have febrile seizures?
No. Genetic susceptibility shifts the threshold — it increases the probability that a given fever could trigger a seizure, but it is not deterministic. Environmental factors including the height of the fever, how rapidly it rises, hydration status, and the child's current developmental stage all contribute. Many children with variants associated with susceptibility will go through the febrile years without a single seizure. The result is best understood as context that informs preparedness and fever management conversations with a pediatrician, not as a certainty of outcome.
Will my child develop epilepsy after febrile seizures?
Most children who experience febrile seizures — even multiple ones — do not go on to develop epilepsy. The overall lifetime risk of epilepsy after simple febrile seizures is only modestly elevated above the general population background rate. The risk is higher after complex febrile seizures, particularly prolonged ones or those with focal features, and in children who have other neurological risk factors. Genetic susceptibility variants near SCN1A, SCN2A, and ANO3 as identified in population GWAS research are associated with febrile seizure threshold, not with epilepsy progression directly. A child who outgrows febrile seizures — which the large majority do by age five — is not on a predetermined path to epilepsy.
Should I avoid the MMR vaccine if my child has susceptibility variants?
No. The MMR vaccine remains recommended for all eligible children regardless of febrile seizure history or susceptibility. Febrile seizures sometimes associated with MMR vaccination are brief, self-limiting, and a known post-vaccination phenomenon — not a signal to avoid vaccination. The genetic signals in this trait studied febrile seizures outside the MMR vaccination context, meaning the variants reflect constitutional susceptibility independent of the post-MMR fever mechanism. Discuss your child's history with your pediatrician before vaccination so a post-vaccine fever monitoring plan is in place.
What should I tell my child's school or daycare about febrile seizures?
Inform the school nurse and caregivers about the history of febrile seizures and the response plan your pediatrician has established. Provide written instructions covering: when to call emergency services (seizure lasting more than five minutes, or the child does not recover consciousness promptly), basic first aid steps (place on side, do not restrain, do not put anything in the mouth), and emergency contact information. An individualized health plan from your pediatrician formalizes this communication.
Is this trait relevant for adults?
Febrile seizures are almost exclusively a pediatric phenomenon. The narrow developmental window of susceptibility — six months to five years — closes as the brain matures and sodium channel expression patterns shift. Adults carrying variants associated with febrile seizure susceptibility are not at elevated risk for adult-onset febrile seizures; the developmental biology that creates the vulnerability is no longer active. For adults, the result is most relevant in the context of family planning and understanding heritable risk to children, or retrospectively in understanding a personal childhood history of febrile seizures.
References
- Feenstra B, Pasternak B, Geller F, et al. (2014). Common variants associated with general and MMR vaccine-related febrile seizures. Nature Genetics, 46(12), 1274–1282. PMID: 25344690.
Wellness Information. ExomeDNA provides educational interpretation of genetic variants for general wellness purposes only. This is not a clinical finding, treatment recommendation, or clinical genetic test. Consult a healthcare provider before making medical decisions. See our methodology and test limitations for details.
This page is published by ExomeDNA. We interpret raw genetic data into educational genetic insights using polygenic scoring with ancestry calibration. Read our methodology for the full statistical approach.
Last reviewed: 2026-05-29.